The increasing use of medications like Ozempic for weight loss continues to spark debate, not just about their efficacy, but also about the psychological and physiological challenges individuals face when discontinuing them. A recent column by Dutch journalist Vera Spaans, age 48, details her experience of regaining weight and experiencing persistent hunger in the first week after stopping Ozempic, highlighting the complex relationship between medication, appetite, and the body’s natural set point. This experience resonates with a growing number of individuals exploring the use of these drugs and raises critical questions about long-term sustainability and the potential for dependence.
Ozempic, originally developed as a medication to manage type 2 diabetes, contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. As reported by Dutch radio station NPO Radio 1, the drug works by mimicking the effects of GLP-1, a hormone that regulates appetite and blood sugar levels. This leads to reduced hunger, slower stomach emptying, and weight loss. Yet, Spaans’ account underscores the potential difficulties encountered when attempting to maintain weight loss without continued pharmaceutical intervention.
The “Valsspelen” (Cheating) Feeling and the Search for a Weight Set Point
Spaans, in her series “Vera speelt vals” (Vera plays dirty) for Het Parool, initially described using Ozempic as feeling like “cheating.” According to Headliner.nl, this sentiment stemmed from the ease with which she experienced weight loss, contrasting sharply with previous struggles. Her recent column details the immediate physical consequences of stopping the medication – a one-kilogram weight gain and, crucially, a constant feeling of hunger. This experience prompted her to question the existence of a “set point” for weight, a theoretical metabolic weight the body strives to maintain.
The concept of a weight set point, while debated among scientists, suggests that each individual has a biologically determined weight range. When weight deviates from this range, the body initiates physiological responses to restore it, including changes in metabolism, appetite, and hormone levels. Spaans’ experience aligns with this theory, as her body appears to be actively working to regain lost weight after Ozempic use was discontinued. However, it’s important to note that the set point is not necessarily fixed and can be influenced by factors such as diet, exercise, and genetics.
Ozempic and the Broader Trend of Weight Loss Medications
The popularity of Ozempic and similar drugs, such as Wegovy (also containing semaglutide), has surged in recent years, driven by a desire for rapid and effective weight loss. These medications have become widely used, even among individuals without diabetes, leading to supply shortages and ethical concerns. The ease of access and perceived effectiveness have fueled a societal conversation about the role of medication in managing weight and the potential for creating unrealistic expectations.
The underlying mechanisms of GLP-1 receptor agonists extend beyond appetite suppression. They also influence insulin sensitivity and glucose metabolism, making them beneficial for individuals with type 2 diabetes. However, the off-label use of these drugs for weight loss raises questions about appropriate prescribing practices and the potential for adverse effects. Common side effects include nausea, vomiting, diarrhea, and constipation. More serious, though less common, side effects have also been reported, including pancreatitis and gallbladder problems. As Vera Spaans notes in her column, the psychological impact of these medications – the feeling of “cheating” and the potential for dependence – is also a significant concern.
The Mental and Emotional Toll of Medication-Assisted Weight Loss
Spaans’ exploration of her experience with Ozempic goes beyond the purely physical effects. She delves into the emotional and moral complexities of using medication to alter one’s body. The question of whether it’s possible to remain content with oneself when external factors, such as a drug, are dictating weight and appetite is central to her reflections. This raises broader questions about body image, self-acceptance, and the societal pressures surrounding weight.
The reliance on medication for weight loss can potentially disrupt the natural feedback mechanisms that regulate appetite, and satiety. Over time, the body may become less responsive to these signals, making it more difficult to maintain weight loss without continued medication. The psychological dependence on the drug can create a cycle of reliance, where individuals fear regaining weight and experience unable to manage their weight without pharmaceutical assistance. The experience of intense hunger upon discontinuation, as reported by Spaans, exemplifies this challenge.
Navigating Discontinuation and Sustainable Weight Management
For individuals considering discontinuing Ozempic or similar medications, a gradual approach under medical supervision is crucial. Abruptly stopping the medication can lead to rapid weight regain and exacerbate feelings of hunger and deprivation. A healthcare professional can assist develop a personalized plan that includes dietary modifications, increased physical activity, and behavioral strategies to support long-term weight management.
Sustainable weight management requires a holistic approach that addresses not only physical health but also emotional and psychological well-being. Focusing on mindful eating, regular exercise, stress management, and cultivating a positive body image are essential components of a healthy lifestyle. While medications like Ozempic can be a valuable tool for some individuals, they should be viewed as part of a comprehensive strategy, not a quick fix.
The case of Vera Spaans serves as a poignant reminder that weight loss is not simply a matter of biology or willpower. It is a complex interplay of physiological, psychological, and social factors. Her willingness to share her personal experience contributes to a much-needed conversation about the challenges and complexities of weight management in the age of readily available weight loss medications.
As more individuals explore the use of these drugs, ongoing research is needed to better understand their long-term effects, optimal usage guidelines, and the psychological impact of both use and discontinuation. The next step in understanding the long-term effects of Ozempic will be the release of further data from ongoing clinical trials, expected in late 2026. Readers are encouraged to consult with their healthcare providers to discuss the potential benefits and risks of these medications and to develop a personalized weight management plan that aligns with their individual needs and goals.